RET and non-small cell lung carcinoma: For example, several fusion genes (ALK, ROS1, RET, and NTRK) are currently recommended actionable molecular biomarkers for non-small cell lung cancer (NSCLC) by the American Society of Clinical Oncology (ASCO) guidelines [8].